On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

CannabisNewsBreaks – ABcann Global Corporation (TSXV: ABCN) Extends Role of “Father of Marijuana Research” Raphael Mechoulam

Company: ABcann Global Corporation (ABCN)
Category: News

In a news release issued early Tuesday, ABcann Global Corporation (TSXV: ABCN) announced that Raphael Mechoulam has agreed to extend his role as an advisor to the company. Aaron Keay, CEO and director of ABcann, spoke to the importance of this agreement in the news release. “Professor Mechoulam’s experience in medicinal cannabis is an invaluable resource for ABcann as we enter the most aggressive growth stage in the company’s history,” he stated. “The Company has invested heavily to build and extend its early leadership in advanced pharmaceutical-grade cannabis production. Professor Mechoulam’s advice, guidance, and unmatched expertise in the field has played a major role in achieving this.” Mechoulam is an Israeli organic chemist who is commonly regarded as the “Father of Marijuana Research.” Working in the field for more than five decades, some of his most noteworthy research accomplishments include determining the chemical structure of cannabidiol (CBD) in 1963, isolating and synthesizing tetrahydrocannabinol (THC) in 1964 and elucidating the structure of the brain’s first endogenous cannabinoid in 1992.

To view the full press release, visit http://nnw.fm/5ScTg

To learn more about ABcann Global Corporation, visit http://nnw.fm/M6Ibv

About ABcann Global Corporation

ABcann Global Corporation is a globally licensed, cost efficient producer of premium quality organic standardized medicinal cannabis. Its flagship operation, ABcann Medicinals Inc., was one of the first companies to obtain a production license under Canada’s Marihuana for Medical Purposes Regulations, which were enacted in July 2013. Since 2014, the company has focused on changing the face of medical cannabis. Today, every variable in its growing, curing and harvesting process is controlled and monitored by computer. This indoor, high-tech growing environment has resulted in a superior product that’s clean, consistent and repeatable; qualities that physicians and patients are looking for. For more information, visit the company’s website at www.ABcannGlobal.com

About NetworkNewsBreak

NetworkNewsBreak (NNB) provides a rapid summary of corporate news that caught the attention of CannabisNewsWire (CNW). NNB keeps you up-to-date on active US Public Companies complementary to CNW’s broader scope as a provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Please see full disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Official NewsWire Relationships

Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo USA CBD Expo

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722